Search results
Oct 3, 2023 · Through these agreements Novavax's updated COVID-19 vaccine will be widely available across the U.S., including but not limited to, Costco, CVS Pharmacy, Giant, Publix, Rite Aid and Stop & Shop. Novavax's vaccine received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) on October 3, 2023.
Oct 20, 2022 · The FDA approved a 2023-2024 Novavax vaccine in October 2023 for ages 12 and older to target the SARS-CoV-2 XBB.1.5 strain a few weeks after newly updated Pfizer-BioNTech and Moderna mRNA vaccines were approved. Novavax’s version replaces its original vaccine, which was found to be 90% effective in its initial clinical trials.
- 065208055
- kathy.katella-cofrancesco@yale.edu
Sep 11, 2023 · Novavax will present the latest data on its vaccine at ACIP’s September 12, 2023, meeting to discuss fall COVID vaccination. Novavax’s updated XBB version of its COVID vaccine is currently under review by the U.S. Food and Drug Administration (FDA) for EUA to prevent COVID-19 in individuals aged 12 and older.
- Why Is There A Delay in Rolling Out The Vaccines?
- How Much of The Vaccine Will Be Available, and Who Will Be Able to Get It?
- Where Will I Be Able to Get It?
- What Was The Reason For The Previous Delays?
The federal approach to rolling out Novavax's vaccine marks a departure from the high-profile campaigns to quickly deploy previous brands, like Pfizer-BioNTech or Moderna. Those shots saw shipments begin within days after they were first authorized. At least part of the delay in supplying Novavax's doses appears to be the result of quality testing ...
Approximately three million doses of Novavax's vaccine will be made available for health departments to request in total. The Biden administration has urged states to direct doses from their "one-time" allocation "to providers with expected demand among unvaccinated patients." Around 1 in 10 American adults have yet to get at least one COVID-19 vac...
It's unclear how those initial batches of Novavax's vaccine will be divided up by the Biden administration between states and other federal vaccination channels like drug stores or health centers. For example, the CDC says its federal retail pharmacy program had administered morethan 250 million doses in the COVID-19 vaccination campaign through ea...
This timeline is the latest delay for Novavax's vaccine reaching unvaccinated adults, now more than six weeks after the company's shots won the near-unanimous backing of the FDA's outside vaccine advisers on June 7. The FDA did not grant emergency authorization for the company's shots until July 13. Documents published by the FDA this weekreveal th...
- tina@cbsnews.com
- 3 min
The FDA amended the emergency use authorization of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. The updated vaccine ...
Jul 19, 2022 · Novavax’s COVID-19 vaccine, which will be available in the coming weeks, is an important tool in the pandemic and provides a more familiar type of COVID-19 vaccine technology for adults. Having multiple types of vaccines offers more options and flexibility for the public, jurisdictions, and vaccine providers.
Jul 11, 2022 · Latest vaccine will provide an additional option for the American public, pending FDA Emergency Use Authorization and CDC recommendation. The U.S. Department of Health and Human Services (HHS), in collaboration with the Department of Defense (DOD), today announced that it has secured 3.2 million doses of Novavax’s COVID-19 vaccine.
